AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOVIRICIDES, INC. Director's Dealing 2009

Sep 29, 2009

34915_dirs_2009-09-29_6d0dd661-bc0f-451b-9a19-4013af237455.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC.OB)
CIK: 0001379006
Period of Report: 2009-09-25

Reporting Person: Theracour Pharma, Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-09-25	Common Stock	S	17500	$0.88	Disposed	34163500	Direct
2009-09-28	Common Stock	S	20000	$.85	Disposed	34143500	Direct

Footnotes

F1: Represents shares of common stock sold in accordance with TheraCour's Rule 10b5-1 Trading Plan adopted with the Registrant as disclosed on Form 8-K on February 10, 2009.